Lenzing, Puts

Lenzing Puts EUR 50 Million Behind Nonwovens While Heiligenkreuz Hangs on Nonbinding Bids

Published on 11/18/2026 at 08:41 | Editorial boerse-global.de
Lenzing commits EUR 50 million to nonwovens expansion in the US and Austria, while reviewing nonbinding bids for its Heiligenkreuz plant.
Lenzing Puts EUR 50 Million Behind Nonwovens While Heiligenkreuz Hangs on Nonbinding Bids Illustration mit AI erstellt.

Lenzing has earmarked EUR 50 million for its nonwovens business, pairing a US capacity build-out with an already-announced Austrian project — a firm spending commitment that sits in stark contrast to the loose, nonbinding nature of the bids now on the table for its Heiligenkreuz plant.

The centrepiece of the investment programme is EUR 27 million for the Mobile site in Alabama, where the company intends to expand capacity for specialty fibres. The remaining EUR 23 million covers the previously announced expansion at the Lenzing site in Austria. Both legs of the package were disclosed on 12 November.

A plant caught between a buyer and a closure

Heiligenkreuz is travelling a different road. Lenzing has received several nonbinding purchase offers for the facility and is reviewing them, with a decision on whether a viable sale can be reached due by the end of 2026. Failing that, the site is slated to close at the end of the first quarter of 2027.

Should investors sell immediately? Or is it worth buying Lenzing?

The distinction matters for anyone weighing the equity. The existence of interested parties is not the same as a workable deal — what counts is whether their offers can be turned into an executable solution. A credible agreement would open an alternative to the planned shutdown, though the financial benefit would depend entirely on its terms. Several bids do not by themselves raise the odds of a completed transaction, and if the sale route falls through, the announced closure remains the fallback.

Investors weigh two very different degrees of certainty

That gap in decisiveness — a committed investment on one side, contingent expressions of interest on the other — means the two projects do not support a single, uniform verdict on where Lenzing is heading. The specialty-fibre expansion signals a clear strategic direction; Heiligenkreuz's next step rests on the outcome of an ongoing review. Nor should the spending programme be mistaken for a business result already banked: the outlays underwrite planned capacity growth, while any economic payoff would have to be assessed separately. A favourable reading would need to account for both the site solution and the execution of the investments.

Shares came under pressure on Tuesday, slipping 3.4%, as European equities weakened after the US tightened restrictions on AI chip sales to China. The stock was also down 0.9% in pre-market trading.

The near-term marker for shareholders is the promised clarity by the end of 2026. What matters by then is not how many suitors appeared, but what binding position Lenzing has managed to reach.

Ad

Lenzing Stock: New Analysis - 18 November

Fresh Lenzing information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Lenzing analysis...

Disclaimer...
en | AT0000644505 | LENZING | boerse | 70530035 |